Pharmaceutical Filtration Market Report 2026

The pharmaceutical filtration market size has grown strongly in recent years. It will grow from $7.65 billion in 2025 to $8.07 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to stringent regulatory compliance, increasing pharmaceutical manufacturing activities, rising demand for sterile products, technological advancements in filtration techniques, expansion of biopharmaceutical production facilities.

The pharmaceutical filtration market size is expected to see strong growth in the next few years. It will grow to $10.01 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growth of biologics and biosimilars, adoption of single-use systems, integration of automation and smart manufacturing, increasing investment in aseptic processing, rising need for contamination-free production. Major trends in the forecast period include advanced filtration membrane development, single-use filtration system adoption, integration of iot in filtration monitoring, automated filtration processes, high-purity water and air filtration demand.

The growing demand for generic drugs is expected to drive the growth of the pharmaceutical filtration market in the future. Generic pharmaceuticals are medications designed to be identical to existing approved brand-name drugs. Pharmaceutical filtration plays a key role in the production of generic drugs by removing solid particulate matter from liquids or gases through a porous medium. For example, in July 2025, the U.S. Food and Drug Administration (FDA) reported that the U.S. healthcare system saved over $400 billion due to the availability of generic medicines. As a result, the increased demand for generic drugs is contributing to the growth of the pharmaceutical filtration market.

Major companies in the pharmaceutical filtration market are forming strategic partnerships to improve downstream purification processes for exosome production. Strategic partnerships allow companies to leverage each other's strengths and resources for mutual benefits. For instance, in January 2023, RoosterBio Inc., a U.S.-based biopharmaceutical company, announced a strategic collaboration with Sartorius AG, a Germany-based pharmaceutical and laboratory equipment company. The partnership aims to provide expertise and solutions for an exosome manufacturing platform using human mesenchymal stem/stromal cells (hMSCs). The goal is to achieve industry-leading potency, purity, and yield. The collaboration will focus on developing analytical methods to characterize exosomes and other extracellular vesicles (EVs), which will help establish quantitative quality control strategies for exosome purification and final drug products. The partnership will also offer scalable filtration equipment, such as Sartoflow Smart and Sartoflow Advanced, to improve the clarity, concentration, and formulation of the products.

In May 2023, Xylem Inc., a U.S.-based water technology provider, acquired Evoqua Water Technologies for $7.5 billion. This acquisition strengthens Xylem's ability to meet the growing demand for sustainable water solutions while enhancing its operational capabilities and market presence. Evoqua Water Technologies, a U.S.-based provider of pharmaceutical filtration solutions, is now part of Xylem's expanded portfolio.

Major companies operating in the pharmaceutical filtration market are 3M Health Care, Danaher Corporation, Amazon Filters Ltd., Eaton Corporation PLC, GE Healthcare, Graver Technologies LLC, Meissner Filtration Products, Parker Bioscience Filtration, Sartorius AG, Repligen, Porvair PLC, Alfa Laval AB, Corning Incorporated, Thermo Fisher Scientific, Freudenberg Group, Avantor Inc., Berry Global Inc., Cantel Medical Corp., Cole-Parmer Instrument Company LLC, Donaldson Company Inc., Entegris Inc., Filtration Group Corporation, Synder Filtration Inc, GVS S.p.A., Koch Membrane Systems Inc., Lenntech B.V., Mann+Hummel Group, Membrane Solutions, Pall Corporation.

North America was the largest region in the pharmaceutical filtration market in 2025. The regions covered in the pharmaceutical filtration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical filtration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have created challenges for the pharmaceutical filtration market by increasing the cost of imported membranes, filter cartridges, and single-use filtration systems, particularly affecting Asia-Pacific manufacturing hubs like China and India. These tariffs have slowed procurement and disrupted supply chains for critical filtration equipment, impacting final product processing and raw material filtration segments. While cost pressures are a concern, tariffs have also encouraged regional manufacturing investments and the adoption of locally sourced filtration solutions, driving innovation in high-purity filtration technologies.

The pharmaceutical filtration market research report is one of a series of new reports that provides pharmaceutical filtration market statistics, including pharmaceutical filtration industry global market size, regional shares, competitors with a pharmaceutical filtration market share, detailed pharmaceutical filtration market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical filtration industry. This pharmaceutical filtration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmaceutical filtration is a technique used to remove solid particulate matter from fluids, which can be either liquid or gas, by using a porous medium. It is widely employed in the pharmaceutical production sector to eliminate pollutants such as particulate matter and bacteria from solids, air, liquids, and gases.

The main products in pharmaceutical filtration include membrane filters, prefilters, depth media, single-use systems, cartridges and capsules, filter holders, and filtration accessories. Membrane filters control the flow of fluids or gases while blocking the passage of particles and microorganisms. Various filtration techniques used in the process include microfiltration, ultrafiltration, crossflow filtration, and nanofiltration, which are applied across different scales of operation such as manufacturing, pilot scale, and research and development. Key applications of pharmaceutical filtration include final product processing, raw material filtration, bioburden testing, cell separation, water purification, and air purification.

The pharmaceutical filtration market includes revenues earned by entities by providing reverse osmosis, sterile filtration, chromatography, sterile sampling and nanofiltration. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.